CompletedNCT01065259
Concerta or Strattera for executive skills in children with ADHD
About this title
Read the official source — NCT01065259Medication studyAges 6–16China
Understand this study
Who was this study for?
Listed age limits: 6 years to 16 years.
- Listed locations
- BeijingSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateApril 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 262
- Sponsor
- Peking University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- From 6 Years to 16 Years
- Official registry ID
- NCT01065259
- Official title
Show the full official title
Randomized Control Study of Concerta and Strattera on the Improvement of Executive Function in Attention Deficit Hyperactivity Disorder Children
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Beijing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Peking University, a university.
Did this study involve medication?
Yes. The study involved medication, including OROS MPH and Atomoxetine.
Who was this study for?
Listed age limits: 6 years to 16 years.
